ErbB2-Positive Stage I-III Breast Cancer
1 clinical trials · Condition
◉ Watch ErbB2-Positive Stage I-III Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer (NCT01309607) | National University Hospital, Singapore | 2011-04-01 |
Track ErbB2-Positive Stage I-III Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.